Incretin Mimetics

lso known as glucagon-like peptide-1 (GLP-1) receptor agonists, are a class of drugs that treat type 2 diabetes and obesity. They work by mimicking the body’s natural hormones to stimulate insulin release, which helps lower blood sugar.